Search details
1.
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
Br J Cancer
; 130(3): 434-441, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38102226
2.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 33-43, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31838010
3.
Management of Infection and Febrile Neutropenia in Patients with Solid Cancer. / Manejo de la infección y la neutropenia febril en el paciente con cáncer sólido.
Enferm Infecc Microbiol Clin
; 35(7): 451-460, 2017.
Article
in English, Spanish
| MEDLINE | ID: mdl-26279208
4.
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
Support Care Cancer
; 24(1): 499-507, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26431960
5.
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study.
Support Care Cancer
; 23(9): 2833-40, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26081597
6.
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.
Eur Urol Oncol
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38582650
7.
The role of pharmacogenomics in metastatic renal cell carcinoma.
Cancer Metastasis Rev
; 31 Suppl 1: S29-32, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22723081
8.
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ther Adv Med Oncol
; 15: 17588359221148921, 2023.
Article
in English
| MEDLINE | ID: mdl-36743520
9.
SEOM clinical guideline emesis (2021).
Clin Transl Oncol
; 24(4): 712-723, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35347571
10.
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06).
Lancet Oncol
; 11(4): 350-7, 2010 Apr.
Article
in English
| MEDLINE | ID: mdl-20163987
11.
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC.
Rev Esp Cardiol (Engl Ed)
; 74(5): 438-448, 2021 May.
Article
in English, Spanish
| MEDLINE | ID: mdl-33712348
12.
Erratum to: Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study.
Support Care Cancer
; 23(9): 2841, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26166000
13.
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
Target Oncol
; 14(1): 15-32, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30694442
14.
Correction to: SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021).
Clin Transl Oncol
; 24(7): 1442, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35567734
15.
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021)
Clin. transl. oncol. (Print)
; 24(4): 712-723, abril 2022. tab
Article
in English
| IBECS (Spain) | ID: ibc-203775
16.
Correction to: SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021)
Clin. transl. oncol. (Print)
; 24(7): 1422, julio 2022.
Article
in English
| IBECS (Spain) | ID: ibc-203843
17.
Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.
Clin Transl Oncol
; 19(3): 341-356, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27562312
18.
A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOGUG-CEC-2011-01).
Eur Urol Focus
; 3(4-5): 430-436, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28753791
19.
Estratificación, monitorización y control del riesgo cardiovascular en pacientes con cáncer. Documento de consenso de SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC y AECC / Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
Rev. esp. cardiol. (Ed. impr.)
; 74(5): 438-448, may. 2021. tab
Article
in English, Spanish
| IBECS (Spain) | ID: ibc-232558
20.
Soporte nutricional y nutrición parenteral en el paciente oncológico: informe de consenso de un grupo de expertos / Nutritional support and parenteral nutrition in cancer patients: An expert consensus report
Endocrinol. diabetes nutr. (Ed. impr.)
; 65(supl.1): 19-23, mar. 2018. tab, ilus
Article
in Spanish
| IBECS (Spain) | ID: ibc-172973